The usefulness of ethylephrine (Efortil-R) in the treatment of priapism and intraoperative penile erections
- PMID: 1281144
- DOI: 10.1007/BF02550631
The usefulness of ethylephrine (Efortil-R) in the treatment of priapism and intraoperative penile erections
Abstract
We present our experience in the treatment of 8 patients with priapism after intravenous injection of vasoactive drugs, and of 15 patients with persistent erections in the course of transurethral cystoscopy surgery. All of them were treated with intracavernous injection of 10 mg ethylephrine (1 ml Efortil-R). The results were satisfactory in all cases. In one patient we had to draw 75 ml blood and give another 10 mg dose of ethylephrine. We have not observed secondary effects of drug administration except two local haematomas with spontaneous resolution. We consider that this treatment is very useful in the management of patients with persistent erections or priapism because of the excellent results obtained without adverse effects.
Similar articles
-
[Treatment of priapism with intracavernous injection of etilefrine hydrochloride].Masui. 1990 Oct;39(10):1409-12. Masui. 1990. PMID: 1979358 Japanese.
-
[Intracavernous injection of etilefrine hydrochloride in iatrogenic priapism].Hinyokika Kiyo. 1986 Dec;32(12):1879-82. Hinyokika Kiyo. 1986. PMID: 2881462 Japanese.
-
[Sickle cell disease priapism: treatment with intracavernous injections of etilefrine].Med Trop (Mars). 2000;60(1):53-6. Med Trop (Mars). 2000. PMID: 10989788 French.
-
Use of glycopyrrolate to treat intraoperative penile erection. Case report and review of the literature.Reg Anesth. 1994 Nov-Dec;19(6):423-8. Reg Anesth. 1994. PMID: 7848955 Review.
-
[Prolonged drug-induced erection. Treatment and prevention].Ann Urol (Paris). 1988;22(6):411-5. Ann Urol (Paris). 1988. PMID: 3066285 Review. French.
Cited by
-
Conservative and medical treatments of non-sickle cell disease-related ischemic priapism: a systematic review by the EAU Sexual and Reproductive Health Panel.Int J Impot Res. 2024 Feb;36(1):6-19. doi: 10.1038/s41443-022-00592-2. Epub 2022 Aug 22. Int J Impot Res. 2024. PMID: 35995858